Commercial
Advanced Search
  
  
  
  
  
  
  
  
  
  
  
MPattachmentdataPub
  
cbbd8ae6-e131-4fe3-9e84-de1f8f219fbe.aspx
  
MedicalandSurgicalTreatmentofTemporomandibularJointDisorder07.08.03h07.08.03hMedicine (07)Medical and Surgical Treatment of Temporomandibular Joint Disordercbbd8ae6-e131-4fe3-9e84-de1f8f219fbe4519Medical and Surgical Treatment of Temporomandibular Joint Disorder07.08.039/9/2022 10:00 AM
10/10/2022
68152a97-778e-4552-94c8-4ca1732e6cfe.aspx
  
Eculizumab(Soliris®)andRelatedBiosimilars,Ravulizumab-cwvz(Ultomiris®)08.00.84i08.00.84iPharmacy (08)Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris®)68152a97-778e-4552-94c8-4ca1732e6cfe4528Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris®)08.00.849/19/2022 1:00 PM
10/17/2022
72b2ebd5-59d3-45c2-9c2a-a70a677b83ad.aspx
  
PneumaticCompressionTherapyDevices05.00.01n05.00.01nDME (05)Pneumatic Compression Therapy Devices72b2ebd5-59d3-45c2-9c2a-a70a677b83ad4535Pneumatic Compression Therapy Devices05.00.019/23/2022 9:00 AM
{"4536": {"Id":4536,"MPAttachmentLetter":"A","Title":"ICD-10 Codes","MPPolicyAttachmentInternalSourceId":6546,"PolicyAttachmentPageName":"2338a55d-2484-46ce-b498-e9548c7c1308"},}
10/24/2022
74afbcd9-65f3-4d96-bd95-8995043065c0.aspx
  
ChimericAntigenReceptor(CAR)Therapy08.01.43k08.01.43kPharmacy (08)Chimeric Antigen Receptor (CAR) Therapy74afbcd9-65f3-4d96-bd95-8995043065c04540Chimeric Antigen Receptor (CAR) Therapy08.01.439/28/2022 9:00 AM
{"4541": {"Id":4541,"MPAttachmentLetter":"A","Title":"ICD-10 CODES AND NARRATIVES","MPPolicyAttachmentInternalSourceId":6560,"PolicyAttachmentPageName":"940358e1-043e-4889-b782-fe9a11c0ad48"},}
10/31/2022
11ab190d-19c9-4029-a919-4a64585eb231.aspx
  
Aprepitant(Cinvanti™),FosaprepitantDimeglumine(Emend®),Granisetron(Sustol®),andRolapitant(Varubi®)08.01.41d08.01.41dPharmacy (08)Aprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®)11ab190d-19c9-4029-a919-4a64585eb2314510Aprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®)08.01.418/30/2022 10:00 AM
{"4511": {"Id":4511,"MPAttachmentLetter":"A","Title":"Risk of Emesis Without Prophylaxis: Intravenous and Oral Antineoplastic Agents","MPPolicyAttachmentInternalSourceId":6528,"PolicyAttachmentPageName":"8aefe153-4e1e-42cc-af69-a7fb2e5bb80b"},}
11/29/2022
7d28d8ee-4fcf-48ac-aaee-cfd8b31c3bfb.aspx
  
ChemicalPeels11.08.08h11.08.08hSurgery (11)Chemical Peels7d28d8ee-4fcf-48ac-aaee-cfd8b31c3bfb4537Chemical Peels11.08.089/26/2022 2:00 PM
12/26/2022